{"id":"analog-insulin","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypoglycemia"},{"rate":null,"effect":"Weight gain"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Lipodystrophy"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Insulin analogs are synthetic modifications of human insulin designed to improve pharmacokinetic properties such as onset, peak, and duration of action. They bind to the insulin receptor on muscle, adipose, and liver cells to facilitate glucose transport and metabolism, thereby lowering blood glucose levels. Different analogs are engineered for rapid-acting, intermediate, or long-acting profiles to match physiological insulin secretion patterns.","oneSentence":"Analog insulin mimics endogenous insulin to regulate blood glucose by binding to insulin receptors and promoting glucose uptake in peripheral tissues.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:24:44.115Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT07037420","phase":"PHASE2","title":"ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly","status":"RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2025-10-28","conditions":"Acromegaly","enrollment":60},{"nctId":"NCT05539872","phase":"PHASE2, PHASE3","title":"Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy Volunteers","status":"COMPLETED","sponsor":"Amphastar Pharmaceuticals, Inc.","startDate":"2022-08-22","conditions":"Pharmacokinetics, Pharmacodynamics","enrollment":69},{"nctId":"NCT06904846","phase":"NA","title":"To Evaluate the Change in Glucose Parameters in Adult Patients With Type 1 or Type 2 Diabetes From Europe Using the iCan o3 CGM System for 60 Days Period","status":"ENROLLING_BY_INVITATION","sponsor":"Sinocare","startDate":"2025-04-23","conditions":"Diabetes Mellitus, Continuous Glucose Monitoring System","enrollment":70},{"nctId":"NCT02227849","phase":"PHASE4","title":"Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2014-08","conditions":"Type 2 Diabetes Mellitus","enrollment":71},{"nctId":"NCT05220917","phase":"","title":"Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2021-08-01","conditions":"Cardiovascular Events, Type2 Diabetes, Renal Disease","enrollment":781430},{"nctId":"NCT02546401","phase":"PHASE3","title":"Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin Pump","status":"COMPLETED","sponsor":"University Hospital, Brest","startDate":"2015-09","conditions":"Diabetes Type 1","enrollment":22},{"nctId":"NCT07242664","phase":"PHASE1","title":"Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State","status":"RECRUITING","sponsor":"Gan and Lee Pharmaceuticals, USA","startDate":"2025-10-13","conditions":"Type 1 Diabetes Mellitis","enrollment":12},{"nctId":"NCT06880835","phase":"NA","title":"Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery","status":"RECRUITING","sponsor":"Jaeb Center for Health Research","startDate":"2025-06-05","conditions":"Diabetes Mellitus, Type 1","enrollment":30},{"nctId":"NCT01407640","phase":"NA","title":"Diagnosis and Physiopathology of Insulin Allergy","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2012-02-06","conditions":"Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Hypersensitivity","enrollment":55},{"nctId":"NCT05614089","phase":"PHASE4","title":"Human Versus Analogue Insulin for Youth With Type 1 Diabetes in Low-Resource Settings","status":"COMPLETED","sponsor":"Jing Luo","startDate":"2023-03-15","conditions":"Diabetes Mellitus, Type 1, Type 1 Diabetes","enrollment":400},{"nctId":"NCT04760626","phase":"PHASE3","title":"A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2021-03-01","conditions":"Diabetes Mellitus, Type 2","enrollment":1085},{"nctId":"NCT07146347","phase":"PHASE1","title":"Comparison Study of Insulin GZR4 With Insulin Degludec","status":"RECRUITING","sponsor":"Gan and Lee Pharmaceuticals, USA","startDate":"2025-08-15","conditions":"Type 2 Diabetes","enrollment":14},{"nctId":"NCT06717191","phase":"PHASE4","title":"Impact of Introducing Basaglar Insulin to the Treatment Regimen of Youth With Diabetes in Pakistan","status":"COMPLETED","sponsor":"Life for a Child Program, Diabetes Australia","startDate":"2022-06-09","conditions":"Type 1 Diabetes","enrollment":296},{"nctId":"NCT05888961","phase":"NA","title":"Single-center Prospective Longitudinal Study of Taste in Patients With Cognitive Disorders at Different Stages of Severity (Isolated Cognitive Complaint, Minor or Major Neurocognitive Alzheimer-type Disorders) by Analysis of Gustatory Evoked Potentials","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2023-06-12","conditions":"Cognitive Disorders","enrollment":72},{"nctId":"NCT06535789","phase":"PHASE2, PHASE3","title":"Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes","status":"RECRUITING","sponsor":"Jaeb Center for Health Research","startDate":"2025-05","conditions":"Diabetes, Gestational, Pregnancy Complications, Glucose Metabolism Disorders","enrollment":30},{"nctId":"NCT04974528","phase":"PHASE3","title":"Afrezza® INHALE-1 Study in Pediatrics","status":"COMPLETED","sponsor":"Mannkind Corporation","startDate":"2021-09-29","conditions":"Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":319},{"nctId":"NCT06411210","phase":"PHASE2","title":"Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-07-16","conditions":"Diabetes type1, Obesity","enrollment":54},{"nctId":"NCT05725681","phase":"NA","title":"Satiety of High-Protein Ramen Noodles","status":"COMPLETED","sponsor":"Texas Tech University","startDate":"2023-06-01","conditions":"Appetitive Behavior","enrollment":30},{"nctId":"NCT04381429","phase":"PHASE4","title":"Effect of Postprandial Insulin Administration of Faster-acting Insulin Analogue Versus Pre-prandial Administration of Acting-insulin Analogue in Cystic Fibrosis Related Diabetes","status":"TERMINATED","sponsor":"University Hospital, Strasbourg, France","startDate":"2020-08-17","conditions":"Cystic Fibrosis-related Diabetes","enrollment":38},{"nctId":"NCT06855615","phase":"PHASE4","title":"Comparison of Thrice-Daily Premixed Human Insulin with Basal-Bolus Therapy Among Patients with Poorly Controlled Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Hospital Sultanah Aminah Johor Bahru","startDate":"2020-10-01","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":44},{"nctId":"NCT06768281","phase":"NA","title":"Effect of Lidocaine and Ozone in Injection for Myofascial Pain","status":"COMPLETED","sponsor":"Yağmur Malkoc","startDate":"2021-03-25","conditions":"Myofascial Pain Syndromes","enrollment":60},{"nctId":"NCT06577584","phase":"","title":"Comparison of Diabetes Patients - Care Trajectory Versus Convention","status":"NOT_YET_RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2025-02-01","conditions":"Type 2 Diabetes","enrollment":20000},{"nctId":"NCT06674135","phase":"PHASE4","title":"Evaluating the Impact of Introducing Basaglar, a Long-acting Analog Insulin, on Clinical and Quality of Life Outcomes in Youth with Diabetes in Bangladesh","status":"COMPLETED","sponsor":"Life for a Child Program, Diabetes Australia","startDate":"2022-06-01","conditions":"Type I Diabetes","enrollment":202},{"nctId":"NCT02914886","phase":"PHASE4","title":"Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)","status":"COMPLETED","sponsor":"Kinderkrankenhaus auf der Bult","startDate":"2016-09","conditions":"Type 1 Diabetes, Lipoatrophy","enrollment":14},{"nctId":"NCT06624943","phase":"PHASE4","title":"Introducing Biosimilar Insulin Glargine to the Treatment Regimen of Children and Youth with Type 1 Diabetes in Mali","status":"COMPLETED","sponsor":"Life for a Child Program, Diabetes Australia","startDate":"2022-03-14","conditions":"Type 1 Diabetes (T1D)","enrollment":260},{"nctId":"NCT05904743","phase":"PHASE4","title":"INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes","status":"COMPLETED","sponsor":"Mannkind Corporation","startDate":"2023-07-07","conditions":"Diabetes Mellitus, Type 1","enrollment":141},{"nctId":"NCT03380546","phase":"PHASE3","title":"Acarbose and Prandial Insulin for the Treatment of Gestational Diabetes Mellitus.","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-07-04","conditions":"Gestational Diabetes Mellitus in Pregnancy","enrollment":341},{"nctId":"NCT02871089","phase":"NA","title":"Closed Loop From Onset in Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cambridge","startDate":"2017-01","conditions":"Diabetes Mellitus, Type 1 Diabetes","enrollment":96},{"nctId":"NCT03542682","phase":"NA","title":"The Effect of Bolus Speed of Rapid-Acting Insulin Analog Absorption and Action in Individuals With Type 1 Diabetes","status":"COMPLETED","sponsor":"Yale University","startDate":"2018-05-30","conditions":"Type1diabetes","enrollment":11},{"nctId":"NCT04186494","phase":"NA","title":"Effect of Liraglutide vs CPAP on Cardiometabolic Outcomes in Obstructive Sleep Apnea","status":"COMPLETED","sponsor":"St Vincent's University Hospital, Ireland","startDate":"2019-12-02","conditions":"Sleep Apnea, Obstructive","enrollment":30},{"nctId":"NCT04849845","phase":"PHASE4","title":"Afrezza® Dosing Optimization Study","status":"COMPLETED","sponsor":"Mannkind Corporation","startDate":"2021-04-09","conditions":"Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2","enrollment":20},{"nctId":"NCT05543850","phase":"NA","title":"Portable Artificial Pancreas Applied for Youth and Adolescents","status":"COMPLETED","sponsor":"Inreda Diabetic B.V.","startDate":"2022-10-28","conditions":"Diabetes Mellitus, Type 1","enrollment":20},{"nctId":"NCT05389813","phase":"PHASE2, PHASE3","title":"Comparison Between Oxycodone and Pregabalin as Preemptive Analgesia","status":"UNKNOWN","sponsor":"An-Najah National University","startDate":"2021-08-15","conditions":"Anesthesia","enrollment":150},{"nctId":"NCT00357890","phase":"NA","title":"Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)","status":"COMPLETED","sponsor":"Nemours Children's Clinic","startDate":"2005-12","conditions":"Diabetes Mellitus, Insulin-Dependent","enrollment":12},{"nctId":"NCT01100892","phase":"PHASE3","title":"Cystic Fibrosis - Insulin Deficiency, Early Action","status":"COMPLETED","sponsor":"Sydney Children's Hospitals Network","startDate":"2010-12","conditions":"Cystic Fibrosis, Diabetes","enrollment":100},{"nctId":"NCT03770767","phase":"PHASE3","title":"Insulin Fiasp vs. Insulin Novorapid During Pregnancy and Laction in Women With Pre-existing Diabetes","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2019-11-11","conditions":"Diabetes Mellitus, Pregnancy Complications","enrollment":216},{"nctId":"NCT05095259","phase":"NA","title":"Metabolic Adaptation to High-frequent Hypoglycaemia in Type 1 Diabetes","status":"UNKNOWN","sponsor":"Nordsjaellands Hospital","startDate":"2019-12-16","conditions":"Type1diabetes","enrollment":60},{"nctId":"NCT05767255","phase":"PHASE3","title":"Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 Analogue","status":"UNKNOWN","sponsor":"Hospital Universitario San Ignacio","startDate":"2022-12-01","conditions":"Diabetes Mellitus, Type 2 Treated With Insulin","enrollment":66},{"nctId":"NCT05752929","phase":"PHASE4","title":"Comparison of 2 Hyperglycemia-correction Scales in Hospitalized Patients","status":"COMPLETED","sponsor":"Hospital Universitario Clinica San Rafael","startDate":"2016-01-01","conditions":"Diabete Type 2, Hyperglycemia","enrollment":116},{"nctId":"NCT02152124","phase":"","title":"Growth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2014-06-01","conditions":"Acromegaly","enrollment":21},{"nctId":"NCT04860414","phase":"NA","title":"Prospective Monocentric Study of Taste in Patients With Minor or Major Cognitive Disorders Such as Alzheimer's, Through the Analysis of Gustatory Evoked Potentials.","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2021-03-03","conditions":"Cognitive Disorders","enrollment":45},{"nctId":"NCT04075513","phase":"PHASE4","title":"Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients","status":"COMPLETED","sponsor":"Sanofi","startDate":"2019-10-09","conditions":"Type 1 Diabetes Mellitus","enrollment":343},{"nctId":"NCT04371497","phase":"","title":"Switch From U-100 Insulin Analog to U-500 Regular Insulin in Pumps for Type 2 Diabetes","status":"COMPLETED","sponsor":"University Hospital, Caen","startDate":"2011-06-01","conditions":"Type 2 Diabetes Mellitus","enrollment":65},{"nctId":"NCT05249881","phase":"EARLY_PHASE1","title":"\"Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan.\"","status":"UNKNOWN","sponsor":"Aga Khan University","startDate":"2022-03-10","conditions":"Diabetes Mellitus, Type 2, Weight Change, Body","enrollment":300},{"nctId":"NCT04876027","phase":"PHASE4","title":"GLP-1 RAs in Patients With Polycystic Ovary Syndrome (PCOS)","status":"COMPLETED","sponsor":"Shanghai 10th People's Hospital","startDate":"2021-05-15","conditions":"Polycystic Ovary Syndrome","enrollment":68},{"nctId":"NCT03557892","phase":"NA","title":"Sensor-augmented Pump Versus Multiple Daily Injections With Degludec as Basal Insulin for Insulin Therapy in Type 1 Diabetes","status":"COMPLETED","sponsor":"Azienda Ospedaliero-Universitaria Careggi","startDate":"2018-04-01","conditions":"Diabetes Mellitus, Type 1","enrollment":28},{"nctId":"NCT03234491","phase":"PHASE1","title":"Improving Post-Prandial Blood Glucose Control With Afrezza During Closed-Loop Therapy","status":"COMPLETED","sponsor":"Yale University","startDate":"2017-11-22","conditions":"Post-Prandial Hyperglycemia, Post-Prandial Hypoglycemia","enrollment":15},{"nctId":"NCT05360147","phase":"PHASE3","title":"Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Third Military Medical University","startDate":"2021-01-20","conditions":"Type 2 Diabetes Mellitus","enrollment":30},{"nctId":"NCT03406000","phase":"PHASE4","title":"Phase 4 Study to Evaluate Treatment Optimization With Once-daily Insulin Glargine 300 U/mL","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-01-22","conditions":"Type I Diabetes Mellitus","enrollment":170},{"nctId":"NCT03260868","phase":"PHASE4","title":"Evaluation of Virtual Versus Traditional Study Conducted in a Group Pilot Study in Adult Patients With Type 1 Diabetes Mellitus (eStudy)","status":"TERMINATED","sponsor":"Sanofi","startDate":"2017-09-19","conditions":"Type 1 Diabetes Mellitus","enrollment":15},{"nctId":"NCT03336528","phase":"PHASE4","title":"Insulin Degludec and Glargine U100 for Management of Hospitalized and Discharged Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Emory University","startDate":"2018-01-02","conditions":"Type 2 Diabetes","enrollment":180},{"nctId":"NCT02688933","phase":"PHASE4","title":"A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-05-05","conditions":"Type 1 Diabetes Mellitus","enrollment":638},{"nctId":"NCT02735044","phase":"PHASE3","title":"Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Sanofi","startDate":"2016-04-14","conditions":"Type 1 Diabetes Mellitus","enrollment":463},{"nctId":"NCT01499082","phase":"PHASE3","title":"Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin","status":"COMPLETED","sponsor":"Sanofi","startDate":"2011-12","conditions":"Type 2 Diabetes Mellitus","enrollment":807},{"nctId":"NCT04971655","phase":"NA","title":"The Effect of Music Therapy on Pain and Anxiety","status":"UNKNOWN","sponsor":"Abant Izzet Baysal University","startDate":"2021-08-04","conditions":"Diabetes Mellitus, Type 2","enrollment":122},{"nctId":"NCT04031599","phase":"NA","title":"Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels","status":"COMPLETED","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2020-07-10","conditions":"Type 1 Diabetes","enrollment":30},{"nctId":"NCT02898506","phase":"PHASE2","title":"Incretin-based Therapy in Late Preclinical Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Oulu","startDate":"2016-03","conditions":"Type 1 Diabetes","enrollment":13},{"nctId":"NCT02611232","phase":"PHASE2","title":"Incretin-based Therapy in Preclinical Type 1 Diabetes in Adults","status":"UNKNOWN","sponsor":"University of Oulu","startDate":"2015-12","conditions":"Type 1 Diabetes","enrollment":42},{"nctId":"NCT02908087","phase":"PHASE2","title":"Incretin-based Therapy in Early Diagnosed Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Oulu","startDate":"2016-03","conditions":"Type 1 Diabetes","enrollment":13},{"nctId":"NCT04834362","phase":"PHASE4","title":"Insulin for Hyperglycemia in Stroke Trial","status":"COMPLETED","sponsor":"National Institute of Neurosciences and Hospital, Dhaka","startDate":"2021-04-05","conditions":"Hyperglycemia, Stroke, Acute","enrollment":452},{"nctId":"NCT04323462","phase":"PHASE4","title":"Intensive Glycemic Control For Diabetic Foot Ulcer Healing","status":"UNKNOWN","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2021-10-01","conditions":"Diabetic Foot Ulcer","enrollment":326},{"nctId":"NCT04674332","phase":"PHASE2, PHASE3","title":"Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2019-09-01","conditions":"Long Acting Insulin in Control of Gestational Diabetes Mellitus","enrollment":148},{"nctId":"NCT03430284","phase":"PHASE4","title":"Multifactorial Intervention on Diabetes (MIDiab Study)","status":"UNKNOWN","sponsor":"Shandong Provincial Hospital","startDate":"2018-04-01","conditions":"Diabetes Mellitus, Type 2","enrollment":6300},{"nctId":"NCT04146155","phase":"PHASE4","title":"Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2020-05-01","conditions":"Type 2 Diabetes, Peripheral Vascular Disorder Due to Diabetes Mellitus","enrollment":200},{"nctId":"NCT03667053","phase":"PHASE3","title":"Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children","status":"COMPLETED","sponsor":"Zealand Pharma","startDate":"2018-09-28","conditions":"Hypoglycemia","enrollment":42},{"nctId":"NCT04917991","phase":"NA","title":"Comparison Between Olive Oil and Palm Oil-enricHed chOCOlate Spreads (CHOCO) in Healthy Subjects","status":"COMPLETED","sponsor":"Campus Bio-Medico University","startDate":"2019-05-02","conditions":"Healthy Diet","enrollment":20},{"nctId":"NCT04626323","phase":"PHASE2","title":"Randomized Study Comparing Metabolic Surgery With Intensive Medical Therapy to Treat Diabetic Kidney Disease","status":"UNKNOWN","sponsor":"Hospital Alemão Oswaldo Cruz","startDate":"2021-05-25","conditions":"Diabetes Mellitus, Type 2, Kidney Disease, Chronic, Kidney Injury","enrollment":60},{"nctId":"NCT03338010","phase":"PHASE3","title":"A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2018-03-22","conditions":"Type 2 Diabetes","enrollment":536},{"nctId":"NCT04335565","phase":"NA","title":"Stevia Extract and Glucose Homeostasis","status":"WITHDRAWN","sponsor":"Liverpool Hope University","startDate":"2020-03-03","conditions":"Overweight, Obesity","enrollment":""},{"nctId":"NCT03157063","phase":"","title":"Pilot Data Collection for Activity, Adiposity, and Appetite in Adolescents","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2017-01-01","conditions":"Physical Activity, Sedentary Lifestyle, Metabolism","enrollment":64},{"nctId":"NCT02407899","phase":"PHASE4","title":"Protective Effects of Saxagliptin (And Vitamin D3) on β Cell Function in Adult-onset Latent Autoimmune Diabetes","status":"COMPLETED","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2015-03","conditions":"Diabetes Mellitus, Type 1","enrollment":300},{"nctId":"NCT03338023","phase":"PHASE3","title":"A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2018-03-23","conditions":"Type 1 Diabetes","enrollment":272},{"nctId":"NCT02971228","phase":"PHASE2","title":"Feasibility Trial Testing the Bionic Pancreas With ZP4207","status":"COMPLETED","sponsor":"Zealand Pharma","startDate":"2016-11","conditions":"Diabetes Mellitus, Type 1","enrollment":13},{"nctId":"NCT02432976","phase":"PHASE2, PHASE3","title":"Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2015-05","conditions":"Quality of Life","enrollment":64},{"nctId":"NCT03819790","phase":"PHASE4","title":"The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians","status":"COMPLETED","sponsor":"LMC Diabetes & Endocrinology Ltd.","startDate":"2018-10-02","conditions":"Diabetes Mellitus, Type 2","enrollment":119},{"nctId":"NCT04726657","phase":"NA","title":"Comparison of Two Biphasic Insulin Regimens","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2016-01-18","conditions":"Diabetes Mellitus, Type 2","enrollment":36},{"nctId":"NCT04726631","phase":"NA","title":"Insulin in Treatment of Diabetes Mellitus With Pregnancy","status":"COMPLETED","sponsor":"Assiut University","startDate":"2015-01-01","conditions":"Diabetes","enrollment":110},{"nctId":"NCT04690309","phase":"PHASE4","title":"Human Versus Analogue Insulin in Patients After Pancreatectomy.","status":"UNKNOWN","sponsor":"Polish Society of Diabetology","startDate":"2018-07-01","conditions":"Pancreatogenous Diabetes","enrollment":100},{"nctId":"NCT00700154","phase":"NA","title":"Insulin Infusion Diabetes Ulcer","status":"TERMINATED","sponsor":"Karolinska Institutet","startDate":"2011-11","conditions":"Diabetes Mellitus, Insulin Resistance, Hyperglycemia","enrollment":40},{"nctId":"NCT03981627","phase":"PHASE1, PHASE2","title":"A Trial to Assess Safety and Efficacy of ADO09 Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Adocia","startDate":"2019-06-06","conditions":"Type 1 Diabetes Mellitus","enrollment":44},{"nctId":"NCT04196231","phase":"PHASE4","title":"Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)","status":"COMPLETED","sponsor":"University of Campania Luigi Vanvitelli","startDate":"2019-11-27","conditions":"Type 2 Diabetes","enrollment":258},{"nctId":"NCT00700362","phase":"","title":"Insulin Infusion and Infectious Diabetic Foot Ulcers (IIIFU)","status":"WITHDRAWN","sponsor":"Karolinska Institutet","startDate":"2011-12","conditions":"Diabetes Mellitus, Insulin Resistance, Hyperglycemia","enrollment":""},{"nctId":"NCT02846831","phase":"PHASE2","title":"Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes","status":"COMPLETED","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2019-01-24","conditions":"Type 1 Diabetes","enrollment":36},{"nctId":"NCT04222348","phase":"PHASE3","title":"MeDiGes Study: Metformine Use in Gestational Diabetes","status":"UNKNOWN","sponsor":"Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud","startDate":"2016-10-26","conditions":"Diabetes, Gestational, Perinatal Disorder, Puerperal Disorder","enrollment":200},{"nctId":"NCT03018938","phase":"PHASE4","title":"A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2017-02-06","conditions":"Type 2 Diabetes Mellitus","enrollment":814},{"nctId":"NCT00821795","phase":"PHASE4","title":"Veterans Inpatient Insulin Study and Transition to Outpatient Therapy","status":"COMPLETED","sponsor":"Dennis G. Karounos, M.D.","startDate":"2009-03-11","conditions":"Type 2 Diabetes Mellitus","enrollment":120},{"nctId":"NCT04112069","phase":"NA","title":"The Insulin-Only Bionic Pancreas Bridging Study- Pediatric Transitional Study","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2018-07-09","conditions":"Type1 Diabetes Mellitus","enrollment":20},{"nctId":"NCT02043054","phase":"PHASE3","title":"Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)","status":"COMPLETED","sponsor":"University of Leicester","startDate":"2013-12-16","conditions":"Type 2 Diabetes Mellitus, Cardiovascular Disease","enrollment":90},{"nctId":"NCT01856790","phase":"EARLY_PHASE1","title":"Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes","status":"COMPLETED","sponsor":"Jennifer Sherr","startDate":"2013-02","conditions":"Type 1 Diabetes","enrollment":15},{"nctId":"NCT01684943","phase":"NA","title":"Selecting Insulin Analogs for Closed-Loop Control Using Multiplex Pharmacokinetic Profiling","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2010-07","conditions":"Type 1 Diabetes","enrollment":33},{"nctId":"NCT01865760","phase":"NA","title":"Etiology, Assessment and Treatment of Post-gastric Bypass Severe Hypoglycemia","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2013-06","conditions":"Obesity, Hypoglycemia, Surgery","enrollment":33},{"nctId":"NCT03858062","phase":"NA","title":"Algorithm to Control Postprandial, Post Exercise and Night Glucose Excursions in a Portable Closed Loop Format,","status":"COMPLETED","sponsor":"J.H. DeVries","startDate":"2019-03-10","conditions":"Diabetes Mellitus, Type 1","enrollment":36},{"nctId":"NCT01352663","phase":"PHASE3","title":"Immunogenicity Safety Study of Wockhardt's Recombinant Insulin Analogue in Type 1 Diabetic Patients","status":"WITHDRAWN","sponsor":"Wockhardt","startDate":"","conditions":"Type I Diabetes","enrollment":""},{"nctId":"NCT03552523","phase":"NA","title":"The Set-Point Study for Type 2 Diabetes: Evaluating the Use of an Insulin Only Bionic Pancreas System in Type 2 Diabetes","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2017-07-28","conditions":"Type 2 Diabetes Mellitus","enrollment":16},{"nctId":"NCT02987751","phase":"PHASE4","title":"A Study on Comparison of Glargine Plus Glulisine With Premixed Insulin in Type 2 Diabetes Patients","status":"COMPLETED","sponsor":"India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals","startDate":"2016-12-29","conditions":"Type2 Diabetes","enrollment":200},{"nctId":"NCT03565666","phase":"PHASE2, PHASE3","title":"The Insulin-Only Bionic Pancreas Bridging Study","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2018-07-09","conditions":"Type1 Diabetes Mellitus","enrollment":36},{"nctId":"NCT02846857","phase":"PHASE2","title":"Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes","status":"WITHDRAWN","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"","conditions":"Type 1 Diabetes","enrollment":""},{"nctId":"NCT03380325","phase":"NA","title":"The Effect of Iloprost on Capillary Recruitment and Insulin Sensitivity in Type 2 Diabetes","status":"COMPLETED","sponsor":"Amsterdam UMC, location VUmc","startDate":"2016-05-11","conditions":"Diabetes Mellitus, Type 2, Insulin Sensitivity/Resistance","enrollment":15},{"nctId":"NCT03707171","phase":"PHASE3","title":"Effects of Liraglutide on the Cognitive Function in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Third Military Medical University","startDate":"2018-10-01","conditions":"Type 2 Diabetes Mellitus","enrollment":30},{"nctId":"NCT02455076","phase":"PHASE4","title":"Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Emory University","startDate":"2015-09","conditions":"Type 2 Diabetes","enrollment":150}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":135,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Insulin Aspart and Insulin Glargine"],"phase":"marketed","status":"active","brandName":"Analog Insulin","genericName":"Analog Insulin","companyName":"National Institute of Neurosciences and Hospital, Dhaka","companyId":"national-institute-of-neurosciences-and-hospital-dhaka","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Analog insulin mimics endogenous insulin to regulate blood glucose by binding to insulin receptors and promoting glucose uptake in peripheral tissues. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}